Skip to content
Pharma Observatory a Scientist.com platform

Organization (Other)

University of Management and Technology Lahore

ClinicalTrials.gov lists University of Management and Technology Lahore as lead sponsor of 41 trials. It has 3 active development programs.

Other

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

40 0 2022 2027

Trials started per year with this organization as sponsor or collaborator, 1990 onward. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.

2026 is partial: 40 registered with a 2026 start date. The hollow diamonds on the dashed line are a forecast of the full-year count, planned starts included: about 38 in 2026 and about 17 in 2027, the average of the 24 months through October, counted as registered and carried forward. The columns, the lighter one included, count trials registered so far with a start date in the year, planned starts included; the forecast looks ahead to the count for the whole year, so it is not the same measure. This method has not been backtested on organizations. In backtests on conditions with as many trial starts a year as this organization (5 to 20), forecasts made part-way through the year were typically off by about 28 percent and ran about 20 percent low against the count later registered; forecasts made before the year began were off by about 39 percent and ran about 37 percent low against the count later registered. These figures rest on a few years of history (target years from 2018 to 2025, varying by figure), place each condition as it is mapped today rather than as it was then, and score against a count for the newest year that was still being revised. Only condition series were scored. The 2026 forecast is below the 40 already registered with a 2026 start date: at the cutoff, 5 trials were already registered to start in November to December, more than the method's monthly average allows for, and the method does not use those planned starts.

This page covers University of Management and Technology Lahore: 41 lead-sponsored trials and 0 legal-entity registrations.

Get the University of Management and Technology Lahore report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Disease areas (28)

Shown in this order: most trials first.

Disease areas
Disease area Trials
Pain 18
Back Pain 5
Low Back Pain 4
Neck Pain 4
Osteoarthritis 4

Trials by start year as sponsor or collaborator (4)

Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Show the table of trials by start year as sponsor or collaborator
Trials by start year as sponsor or collaborator
Year Trials started
2026 (partial year) 40
2024 1
2023 1
2022 1

Recruitment duration, a model prediction: none of the 1 trial evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

Active development programs (3)

Shown in this order: max phase, then active trials.

Active development programs
Drug Disease area Max phase Trials Ownership basis
Conventional Treatment Pain Not reported 1 Comparator
Conventional Treatment Arthralgia Not reported 1 Comparator
Conventional Treatment Shoulder Pain Not reported 1 Comparator

Journals published in (14)

Shown in this order: most published in first.

Journals published in
Journal Publications
Advances in clinical chemistry 1
Annals of rehabilitation medicine 1
Annals of the rheumatic diseases 1
BMC sports science, medicine & rehabilitation 1
Bone research 1

Latest dated events (43)

Shown in this order: newest first.

Latest dated events
Date Event Source
2026-11-05 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-11-05 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-11-05 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-11-05 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-11-02 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))

Biomarker capability evidence (12)

Shown in this order: tier desc, then gene symbol.

Biomarker capability evidence
Gene Role Evidence
CRP Trial collaborator Named in trial inclusion criteria
LBP Trial sponsor Named in trial inclusion criteria
SLC26A3 Trial sponsor Named in trial inclusion criteria
LBP Trial sponsor Named in trial exclusion criteria
LBP Trial sponsor Named in trial exclusion criteria

Not on this page

Checked, with nothing recorded for this organization: companies grouped under this page, related companies not grouped here, approved assets, sponsor delivery record, us granted patents, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, organization relationships, clia clinical laboratory certificates, and biomarkers this organization publishes on.